Generics

Webcast Provides Perspective on Generic Imatinib

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time [...]

By |2018-10-30T09:55:00-04:00April 8th, 2016|Generics, GIST Education, Newsletter, Webcast|

Generic Imatinib Approved in the US for CML: What does it mean for GIST patients?

Note: The content of this article is current to the time of its posting on February 10, 2016. Please continue to check our site for the latest information on generics. On February 1, 2016, [...]

By |2018-12-17T10:51:32-04:00February 10th, 2016|Drug Treatment, Generics, Gleevec, News, Newsletter|